171 related articles for article (PubMed ID: 33600869)
1. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
Di Genua C; Nerlov C
Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
[TBL] [Abstract][Full Text] [Related]
2. Acute erythroid leukemia.
Zuo Z; Polski JM; Kasyan A; Medeiros LJ
Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
[TBL] [Abstract][Full Text] [Related]
3. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
[TBL] [Abstract][Full Text] [Related]
4. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
[TBL] [Abstract][Full Text] [Related]
5. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.
Chen Y; Pourabdollah M; Atenafu EG; Tierens A; Schimmer A; Chang H
Leuk Res; 2017 Oct; 61():39-43. PubMed ID: 28886412
[TBL] [Abstract][Full Text] [Related]
8. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
[TBL] [Abstract][Full Text] [Related]
9. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
[TBL] [Abstract][Full Text] [Related]
10. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
[TBL] [Abstract][Full Text] [Related]
11. Erythroleukemia: an Update.
Weinberg OK; Arber DA
Curr Oncol Rep; 2021 Apr; 23(6):69. PubMed ID: 33876292
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].
Takeda J
Rinsho Ketsueki; 2022; 63(2):121-133. PubMed ID: 35264503
[TBL] [Abstract][Full Text] [Related]
13. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.
Margolskee E; Mikita G; Rea B; Bagg A; Zuo Z; Sun Y; Goswami M; Wang SA; Oak J; Arber DA; Allen MB; George TI; Rogers HJ; Hsi E; Hasserjian RP; Orazi A
Mod Pathol; 2018 Jun; 31(6):873-880. PubMed ID: 29403082
[TBL] [Abstract][Full Text] [Related]
14. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
15. Erythroid proliferations in myeloid neoplasms.
Wang SA; Hasserjian RP
Hum Pathol; 2012 Feb; 43(2):153-64. PubMed ID: 22154053
[TBL] [Abstract][Full Text] [Related]
16. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
17. C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.
Di Genua C; Valletta S; Buono M; Stoilova B; Sweeney C; Rodriguez-Meira A; Grover A; Drissen R; Meng Y; Beveridge R; Aboukhalil Z; Karamitros D; Belderbos ME; Bystrykh L; Thongjuea S; Vyas P; Nerlov C
Cancer Cell; 2020 May; 37(5):690-704.e8. PubMed ID: 32330454
[TBL] [Abstract][Full Text] [Related]
18. Modeling and targeting of erythroleukemia by hematopoietic genome editing.
Iacobucci I; Qu C; Varotto E; Janke LJ; Yang X; Seth A; Shelat A; Friske JD; Fukano R; Yu J; Freeman BB; Kennedy JA; Sperling AS; Zheng R; Wang Y; Jogiraju H; Dickerson KM; Payne-Turner D; Morris SM; Hollis ES; Ghosn N; Haggard GE; Lindsley RC; Ebert BL; Mullighan CG
Blood; 2021 Mar; 137(12):1628-1640. PubMed ID: 33512458
[TBL] [Abstract][Full Text] [Related]
19. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
20. Pure erythroid leukemia.
Wang W; Wang SA; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
